FIRST DAY

Wednesday September 27th

13.25-13.30 pm - Opening

Welcome and introduction:
Pr Eric Deutsch,
Director of Gustave Roussy Radiation Oncology Department and INSERM UMR 1030

PRIMER ON CANCER IMMUNOLOGY, RADIATIONS AND IMMUNOTHERAPY
Educational Session

13.30-15.30 Part I
Alexandre BOBARD/Eric DEUTSCH

13.30-14.00: INNATE IMMUNITY

Tumor-associated macrophages from bench to bedside
Pr Alberto Mantovani
, Istituto Clinico Humanitas, IT


14.00-14.30: ADAPTIVE IMMUNITY

Role of tertiary lymphoid structures in response to anti-cancer immunotherapy
Pr Antoine Italiano
, Gustave Roussy, FR


14.30-15.00: IMMUNOLOGICAL CELL DEATH

Immunological cell death: inducers and enhancers
Pr Guido Kroemer, Cordeliers Research Center, FR


15.00-15.30: ABSCOPAL EFFECT

Mechanisms of interaction of radiotherapy with immunotherapy
Pr Silvia Formenti, Weill Cornell Medicine, USA


15.30-16.00 Coffee break

Primer on Cancer Immunology, Radiations and Immunotherapy

16.00-18.15 Part II
Ibrahim BOUAKKA/Roger SUN

16.00-16.30: CLINICAL IMMUNOTHERAPY

How to build on the top of current chemo-radiations and PD-L1 inhibitors? The NSCLC model
Pr Fabrice Barlési,
Gustave Roussy, FR


16.30-17.00: DNA DAMAGE RESPONSE

Modulating DNA damage responses to enhance radiotherapy-immunotherapy combinations
Pr Kevin Harrington, Institute of Cancer Research, UK


17.00-17.30: RADIO-IMMUNOTHERAPY

Immunogenic cell death driven by radiotherapy – Mechanisms and implications
Dr Lorenzo Galluzzi, Weill Cornell Medicine, USA


MAIN PROGRAM
Keynote Presentation

17.30-18.15: Understanding mechanisms of action of modern drugs
Pr Fabrice André, Gustave Roussy, FR

18.15-20.00 COCKTAIL POSTER SESSION

 
Cookie Policy

This website uses cookies that are necessary to its functioning and required to achieve the purposes illustrated in the privacy policy. By accepting this OR scrolling this page OR continuing to browse, you agree to our privacy policy.

Cookie Policy